Yamaguchi, Tomoko http://orcid.org/0000-0001-6245-7629
Kuwano, Atsushi
Koyama, Toshihiko
Okamoto, Jun
Suzuki, Shigeyuki
Okuda, Hideki
Saito, Taiichi
Masamune, Ken
Muragaki, Yoshihiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K23349)
Article History
Received: 11 January 2022
Accepted: 9 September 2022
First Online: 23 September 2022
Declarations
:
: T. Yamaguchi, A. Kuwano, T. Saito, K. Masamune and Y. Muragaki declare that they have no conflicts of interest. T. Koyama is an employee of DENSO Corporation. J. Okamoto is Vice President and Chief Operations Officer of SONIRE Therapeutics Inc. S. Suzuki is Chief Technical Officer of OPExPARK Inc. H. Okuda is Executive Vice President and Founder of OPExPARK Inc. and an employee of DENSO Corporation.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.